Log In
Print
BCIQ
Print
Print this Print this
 

Redectane, 124-Iodine-girentuximab (CA9-SCAN)

Also known as: WX-G250RIT

  Manage Alerts
Collapse Summary General Information
Company Wilex AG
DescriptionRadiolabeled WX-G250 antibody
Molecular Target Carbonic anhydrase IX (CAIX)
Mechanism of ActionDiagnostic; Radiolabelled antibody
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase III
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose clear cell renal cell carcinoma (ccRCC)
Regulatory Designation

U.S. - Special Protocol Assessment (Diagnose clear cell renal cell carcinoma (ccRCC))

Partner

Ion Beam Applications S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today